Root Cause

Vitamin D: Why 90% of People in the UK Are Deficient and What It Actually Does

By Hussain Sharifi · March 2026 · 10 min read

You've probably heard that vitamin D is important for your bones. Your GP might have even mentioned it casually, usually in November as the days get shorter. Maybe you were told to get some sunlight or take a supplement if you're feeling tired.

What you probably haven't been told is that 90% of the UK population doesn't have enough vitamin D. And that vitamin D isn't actually a vitamin at all. It's a hormone. A master hormone that sits at the centre of immune regulation, cancer prevention, bone density, mood, and whether your autoimmune system turns against you or stays balanced.

This isn't obscure research. This is epidemiology and cell biology that's been understood for over a decade. Yet the NHS guidance remains stuck at 400 IU daily, a dose that most researchers consider inadequate for anything beyond preventing rickets.

Why the UK is vitamin D deficient by geography and design

Your body manufactures vitamin D when UVB rays from the sun hit your skin. That's the biological reality. But here's the problem: the UK is at 51 degrees north latitude. For six months of the year, from October through March, the sun's angle is too low for UVB rays to reach the earth's surface effectively, even on clear days.

Studies at St Andrews University measured UVB availability across the UK throughout the year. The finding was stark: from November to February, UVB synthesis essentially stops. Even in April and September, it's minimal. You're physically unable to produce meaningful amounts of vitamin D from sun exposure for half the year.

Add to this the obvious: most UK adults spend working hours indoors. You commute in cars. You work at desks. You're inside. Even if UVB was available, most of the population isn't getting it.

The National Diet and Nutrition Survey, which tracks nutritional status across the UK population, has documented this consistently. In winter, median vitamin D levels drop to around 25-30 nmol/L (nanomoles per litre). A third of the adult population falls below 25 nmol/L, which is the threshold for deficiency. The elderly, people with darker skin, and office workers are hit hardest.

The geography problem: If you live north of 35 degrees latitude anywhere on earth, you simply cannot produce sufficient vitamin D from sun exposure during winter months. The UK is at 51 degrees. You're not being lazy or irresponsible if your vitamin D is low. You're at the mercy of geography.

Vitamin D is a hormone, not a vitamin. This distinction matters.

True vitamins are compounds your body cannot manufacture, so you must obtain them from food. Vitamin D is different. Your body produces it. It circulates through your blood. It binds to receptor sites on virtually every cell type in your body. It regulates gene expression. It suppresses or activates entire biological pathways.

That's not a vitamin. That's a hormone.

This distinction is more than semantic. It means your body has a target range for vitamin D. It means deficiency has systemic consequences. It means supplementation at laughably low doses (the NHS recommended 400 IU) is like supplementing thyroid hormone at 5 micrograms when someone's TSH is elevated. Technically you're providing something, but not meaningfully.

Your body maintains vitamin D through complex feedback loops involving parathyroid hormone, calcium, and phosphate. When your vitamin D is low, your parathyroid gland compensates by working harder, pulling calcium from your bones to maintain blood levels. This is fine short-term. Long-term, it's bone loss. It's disease risk. It's accelerated ageing.

Immune function: vitamin D receptors are everywhere

Nearly every immune cell in your body contains vitamin D receptor sites. T cells. B cells. Macrophages. Dendritic cells. Your skin's barrier cells. The cells lining your gut. They all express vitamin D receptors, which means they're all listening for vitamin D signals.

When vitamin D levels are sufficient, these receptors are activated. Your immune system calibrates itself appropriately. It can distinguish between genuine threats and harmless molecules. It mounts a response when needed. It tolerates what's safe. It stays balanced.

When vitamin D is deficient, this signalling breaks down. Your immune system becomes dysregulated. Research by Aranow et al, published in the Journal of Investigative Medicine (2011), systematically documented vitamin D's role in regulating both innate and adaptive immunity. The mechanisms include activation of antimicrobial peptides, modulation of antigen-presenting cells, and regulation of pro-inflammatory and anti-inflammatory cytokines.

In practical terms: low vitamin D correlates with increased infection risk (colds, flu, respiratory infections), worse outcomes from infections, and increased risk of conditions where the immune system malfunctions (autoimmune diseases, allergies, asthma).

What this means: If you're getting frequent infections, or if you have an autoimmune or allergic condition, vitamin D status should be investigated. It's not a cure-all, but normalising vitamin D levels often produces measurable improvements in symptom severity and infection frequency.

Cancer risk and vitamin D: the association is substantial

Multiple meta-analyses have examined the relationship between vitamin D and cancer risk. The evidence is consistent: vitamin D deficiency correlates with increased risk across several cancer types, most notably colorectal and breast cancer.

A major meta-analysis looking at over 700,000 participants found that individuals with vitamin D levels below 50 nmol/L had approximately 50% higher risk of colorectal cancer compared to those with levels above 75 nmol/L. For breast cancer, the association is similar in magnitude.

The mechanisms are understood: vitamin D suppresses cell proliferation, induces differentiation, promotes apoptosis (cell death) in abnormal cells, and modulates immune surveillance against cancer cells. When vitamin D is deficient, these protective mechanisms are impaired.

This doesn't mean vitamin D supplementation prevents cancer. Causation is more complex. But it means that persistent vitamin D deficiency is a modifiable risk factor. Unlike age or genetics, you can address this.

Bone health and the calcium-vitamin D-K2 trilogy

Yes, vitamin D regulates calcium absorption. Your intestines absorb dietary calcium more efficiently when vitamin D is adequate. This is necessary but not sufficient for bone health.

Here's what's often missed: calcium needs direction. You want it in your bones and teeth. You don't want it accumulating in your arteries, your joints, or your soft tissues. That's where K2 enters the picture.

Vitamin K2, specifically the MK-7 form, activates proteins (osteocalcin and matrix Gla protein) that direct calcium to skeletal tissue and away from soft tissue. K2 deficiency leaves you with a problem: you're absorbing calcium efficiently thanks to vitamin D, but it's going to the wrong places.

The research shows that optimal bone health requires adequate vitamin D (measured as sufficient circulating levels), adequate calcium intake, and adequate K2 status. Supplementing one without the others is incomplete.

The practical implication: Supplementing vitamin D alone is better than nothing, but supplementing vitamin D with K2 (MK-7 form) is more effective for bone density. Many supplements combine both.

Mental health, mood, and seasonal affective disorder

The connection between vitamin D and mood is mechanistic, not just correlational. Vitamin D receptors are expressed throughout the brain, including areas involved in mood regulation: the prefrontal cortex, the limbic system, regions involved in serotonin synthesis.

Vitamin D deficiency is associated with depression, seasonal affective disorder (SAD), and impaired stress resilience. This isn't because people with depression spend more time indoors, though that's often part of the pattern. It's because vitamin D deficiency compromises the neurobiological systems that regulate mood.

Research across multiple studies shows that vitamin D supplementation produces measurable improvements in depression scores, particularly in people with baseline deficiency. The effect sizes are clinically meaningful: improvements comparable to low-dose antidepressant medication in some studies.

In the UK, seasonal affective disorder affects millions of people. The onset is predictable: as days shorten in autumn, vitamin D production plummets, mood deteriorates. By the time winter arrives, many people are dealing with both low vitamin D and depressed mood simultaneously.

If you experience seasonal mood changes: Monitor your vitamin D levels. If they're low (below 75 nmol/L), correction often produces noticeable mood improvement within 4-8 weeks. This shouldn't replace treatment for clinical depression, but it's a fundamental factor to address.

Autoimmune disease risk: the tolerance-dysregulation spectrum

Vitamin D plays a critical role in immune tolerance. It promotes the development of regulatory T cells, which suppress inappropriate immune activation. It reduces the production of inflammatory cytokines. It helps your immune system tolerate self-antigens.

Research shows that people with autoimmune conditions (type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Hashimoto's thyroiditis) have significantly lower vitamin D levels than healthy populations. This isn't just an association. Mechanistically, vitamin D deficiency impairs immune tolerance, which increases autoimmune disease risk.

Studies in populations with high vitamin D status show lower prevalence of autoimmune conditions. This is partly geographic: places with more sunlight year-round have both higher vitamin D levels and lower autoimmune disease rates.

This is particularly important for UK populations. You're at a latitude where vitamin D deficiency is endemic. You're also in a region with relatively high rates of autoimmune disease. The connection isn't coincidental.

Why NHS guidance is outdated and inadequate

The NHS recommends 400 IU of vitamin D daily for adults, with slightly higher amounts for elderly people and children. This recommendation is based on preventing rickets and severe deficiency, not on optimising health outcomes.

Most vitamin D researchers and functional medicine practitioners consider 400 IU inadequate for anyone living north of 40 degrees latitude during winter months. The evidence suggests that meaningful health benefits require circulating vitamin D levels of at least 75 nmol/L, with 100-125 nmol/L representing a functional optimisation range.

To achieve these levels starting from deficiency, most people require 2000-4000 IU daily, not 400. Some people require more, depending on body weight, skin tone, age, and absorption capacity.

The NHS guidance exists partly for logistical reasons: recommending higher doses to millions of people creates supply and cost considerations. But scientifically, it's inadequate.

The evidence-based approach: Test your vitamin D level. If you're below 75 nmol/L (30 ng/mL in US measurements), supplementation is warranted. If you're below 50 nmol/L, supplementation is definitely necessary. The dose should be titrated to reach your target range.

D3 versus D2: bioavailability and effectiveness matter

There are two forms of vitamin D supplementation: D2 (ergocalciferol, plant-derived) and D3 (cholecalciferol, animal-derived or synthesised). They're not equivalent.

Research by Tripkovic et al, published in the American Journal of Clinical Nutrition (2012), directly compared D2 and D3 supplementation in a randomised trial. D3 was significantly more effective at raising circulating vitamin D levels. The same dose of D3 produced higher blood levels than D2. When the goal is correcting deficiency, D3 is the better choice.

Additionally, D2 has a shorter half-life in the bloodstream. It's metabolised more quickly. D3 persists longer, meaning you need fewer frequent doses to maintain adequate levels.

If you're supplementing, choose D3, not D2.

Testing and optimal target ranges: what you should aim for

The standard test is 25-OH vitamin D (25-hydroxyvitamin D), measured in nmol/L or ng/mL. This is the form your body uses to assess vitamin D status and the one most clinicians measure.

The thresholds vary slightly by organisation, but broad categories are:

Below 25 nmol/L: deficiency (associated with bone disease and increased disease risk)

25-50 nmol/L: insufficient (suboptimal for immune function and disease prevention)

50-75 nmol/L: minimum adequate (prevents rickets and severe deficiency, but may not optimise non-skeletal health)

75-125 nmol/L: functional optimisation range (where most immune and hormonal benefits are observed)

Above 150 nmol/L: excessive (generally not necessary, risk of toxicity only at extreme levels above 375 nmol/L)

Most researchers and clinicians recommend a functional target of 75-125 nmol/L as optimal for overall health, not just bone health.

Get tested: A 25-OH vitamin D blood test costs around £20-30 privately if your GP won't run it. If you're in the UK and haven't been tested, request it. If you're below 75 nmol/L, supplementation is indicated.

Practical supplementation: dosing, timing, and synergy

If you're deficient, starting supplementation isn't complex. The standard approach is 1000-4000 IU daily depending on your starting level and target.

If you're starting from severe deficiency (below 25 nmol/L), many practitioners use higher loading doses: 5000-10000 IU daily for 2-3 months, then titrate down to a maintenance dose. A follow-up test 8-12 weeks after starting supplementation tells you whether your dose is appropriate.

Take vitamin D with food. It's fat-soluble, so absorption is better with dietary fat. Take it with K2 if you're concerned about bone health or calcium distribution. The synergy is real: together, they work better than separately.

Vitamin D toxicity only occurs at extremely high levels (above 375 nmol/L from supplementation) taken consistently for months. The risks of deficiency far exceed the risks of reasonable supplementation.

Who's most at risk of severe deficiency

Several groups are at highest risk of vitamin D deficiency and should prioritise testing and supplementation:

People with darker skin: Darker skin contains more melanin, which reduces UVB penetration and vitamin D synthesis. People of African, Caribbean, and South Asian descent living at northern latitudes are at particularly high risk.

Elderly people: Older skin synthesises vitamin D less efficiently, even with identical UVB exposure. Reduced mobility and more time indoors compounds this.

Office and indoor workers: If your job is indoors, you're not getting meaningful sun exposure. This affects millions of UK workers.

People with obesity: Vitamin D is fat-soluble and deposits in adipose tissue. Higher body weight requires higher supplementation doses to achieve the same blood levels.

People with malabsorption conditions: Crohn's disease, coeliac disease, IBS, bile acid malabsorption, and other gut conditions impair vitamin D absorption. These populations require higher supplementation.

Anyone living north of 40 degrees latitude during winter: Essentially, if you're in the UK from November through March, you fall into this category.

Practical step: If you fit any of these categories, vitamin D testing and supplementation should be part of your baseline health maintenance, not something you address only if you're symptomatic.

Why this matters right now

Vitamin D deficiency is one of the most prevalent, modifiable nutritional deficiencies affecting the UK population. It sits at the intersection of multiple disease processes: infection risk, cancer risk, autoimmune disease, bone loss, mental health deterioration, and accelerated ageing.

Unlike many health interventions, correcting vitamin D deficiency is inexpensive, straightforward, and the evidence base is robust. You test your level. You supplement appropriately. You retest in 8-12 weeks. You adjust the dose until you're in the optimal range. Done.

Yet most people in the UK are persistently deficient, and most GPs aren't actively investigating or treating this. The consequence is that millions of people are operating with compromised immunity, elevated disease risk, worse mental health, and accelerating bone loss, all from a modifiable deficiency.

The data is clear. The mechanism is understood. The treatment is accessible. What's missing is awareness and action.

Want to understand your vitamin D status and optimise your level?

Request a Confidential Consultation →
Real Client Outcomes
See how structured health intelligence has changed outcomes for real clients — from gut health to women's health to medication optimisation.
View Case Studies → Services & Pricing →